$GSBD Balance Sheet | Understand Stock

$GSBD

$8.57 -$0.05 (0.58%) Close

$GSBD Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Assets and Liabilities

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022
Assets
Investments, at fair value
Non-controlled/non-affiliated investments (cost of $3,616,571 and $3,598,963)
Non-controlled affiliated investments (cost of $71,299 and $69,712)
Non-Controlled/Non-Affiliated Investments
Non-Controlled Affiliated Investments
Total investments, at fair value

Investments in affiliated money market fund, Cost
Cash
Receivable for investments sold
Unrealized appreciation on foreign currency forward contracts
Interest and dividends receivable
Deferred financing costs
Other assets
Total assets

Liabilities
Debt (net of debt issuance costs of $12,777 and $8,169)
Interest and other debt expenses payable
Management fees payable
Incentive fees payable
Distribution payable
Unrealized depreciation on derivatives
Unrealized depreciation on foreign currency forward contracts
Accrued offering costs
Directors’ fees payable
Secured borrowings
Accrued expenses and other liabilities
Total liabilities

Net assets
Preferred stock, par value $0.001 per share (1,000,000 shares authorized, no shares issued and outstanding)
Common stock, par value $0.001 per share (200,000,000 shares authorized, 112,569,067 shares issued and outstanding as of June 30, 2026 and December 31, 2025)
Paid-in capital in excess of par
Distributable earnings (loss)
Allocated income tax expense
Total net assets
Total liabilities and net assets
Net asset value per share

Comments